Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check15 days agoChange DetectedDifference0.4%
- Check22 days agoChange DetectedThe page has undergone significant content removal, including the detailed description of a clinical study for acute myeloid leukemia, which is core information for potential participants. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference12%
- Check29 days agoChange DetectedThe web page has been updated to reflect new results and definitions related to the treatment of acute myeloid leukemia (AML), including changes in the duration of complete remission and the rates of various treatment outcomes. Additionally, the timeline for reporting results has been adjusted, with new dates provided for submissions and postings.SummaryDifference34%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check44 days agoChange DetectedDifference0.2%
Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.